Atlas Trials

Urothelial Carcinoma of the Renal Pelvis and Ureter

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Urothelial Carcinoma of the Renal Pelvis and Ureter

RecordFirmDate
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 ) (NCT07720921)Peking University First Hospital2026-08-01
Bladder EpiCheck European Haematuria Study (NCT06818136)Nucleix Ltd.2025-06-20
Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma (NCT06983210)Nagoya University2025-05-01
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma (NCT06823427)Mabwell (Shanghai) Bioscience Co., Ltd.2025-01-17
Neoadjuvant Radiotherapy for High-risk UTUC (NCT06472752)Peking University First Hospital2024-06-30
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma (NCT06124976)Peter Black2024-06-19
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto (NCT05874921)UroGen Pharma Ltd.2023-11-17
A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma (NCT03606174)Mirati Therapeutics Inc.2018-09-11
Named Patient Program for Mitomycin for Pyelocalyceal Solution (NCT05494411)UroGen Pharma Ltd.

Track Urothelial Carcinoma of the Renal Pelvis and Ureter automatically

Every clearance here is in the API, with alerts when new ones post.